Full Text View
Tabular View
No Study Results Posted
Related Studies
Carbendazim in Treating Patients With Advanced Solid Tumors or Lymphoma
This study is ongoing, but not recruiting participants.
Study NCT00023816   Information provided by National Cancer Institute (NCI)
First Received: September 13, 2001   Last Updated: March 13, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lymphoma
Additional conditions recognized in this trial
Neoplasms
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Interventions listed in this trial
carbendazim
Additional drug interventions recognized in this trial
Mecarzole
More general drug interventions related to this trial
Anthelmintics
Anti-Infective Agents
Antinematodal Agents
Antiparasitic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services